Ajinomoto USA, INC.
11
0
0
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Leucine Enriched Essential Amino Acid Powder as an Add-on to a Classic Ketogenic Diet in Refractory Epilepsy
Role: collaborator
Effect of a Complementary Food Supplement on Growth and Morbidity of Ghanaian Infants
Role: collaborator
The Effects of Aspartame on Appetite, Body Composition and Oral Glucose Tolerance
Role: collaborator
Effects of Infant Formula Composition on Infant Feeding Behaviors
Role: collaborator
Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate
Role: collaborator
Effects of Monosodium Glutamate on Energy Balance and Eating Behavior
Role: collaborator
Effects of Alanine in Patients With Nonalcoholic Steatohepatitis
Role: collaborator
Impact of Varying Doses of Amino Acids on Exercise, Muscular and Mental Performance
Role: collaborator
Effect of Chili Pepper Extract on Weight and Fat Loss and Metabolism Increase
Role: lead
The Acute Effects of Capsiate During Exercise
Role: collaborator
Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients
Role: collaborator
All 11 trials loaded